Latest filing published 07 Feb 2025 for Avid Bioservices, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Catherine J. Mackey is a declared insider at 3 companies (board member); the most frequent names are Avid Bioservices, Inc., GW Pharmaceuticals PLC and Sequenom Inc. In total, 7 filings cover trades dated from 4 January 2016 to 5 February 2025.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 7 February 2025 came the latest disclosure, a transaction in Avid Bioservices, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations